Predicting AIDS-related events using CD4 percentage or CD4 absolute counts

AIDS Research and Therapy

Volumn 3, Issue 1, 2006, Pages

  Pirzada, Yasmin ^a   Khuder, Sadik ^a   Donabedian, Haig ^a  

^a MEDICAL COLLEGE OF OHIO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; CD4 ANTIGEN; CD8 ANTIGEN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; AGED; AIDS RELATED COMPLEX; ARTICLE; ASPERGILLOSIS; ASPERGILLUS; BACTERIAL PNEUMONIA; CANDIDA; CARDIOMYOPATHY; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; COLITIS; CONTROLLED STUDY; CRYPTOCOCCUS; CRYPTOSPORIDIUM; CYTOMEGALOVIRUS; DEMENTIA; DRUG EFFICACY; ENTERITIS; ESOPHAGITIS; ESOPHAGUS CANDIDIASIS; FEMALE; FUNGAL MENINGITIS; HERPES SIMPLEX; HERPES SIMPLEX VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; IMMUNE DEFICIENCY; KAPOSI SARCOMA; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MICROSPORIDA; MYCOBACTERIOSIS; MYCOBACTERIUM AVIUM; MYCOBACTERIUM TUBERCULOSIS; NONHODGKIN LYMPHOMA; PANCYTOPENIA; PNEUMOCYSTIS CARINII; PNEUMOCYSTIS PNEUMONIA; PREDICTION; PRIORITY JOURNAL; PROBABILITY; PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY; RELIABILITY; RETINITIS; SPINAL CORD DISEASE; TIME; TOXOPLASMA; TOXOPLASMOSIS; TREATMENT OUTCOME; TUBERCULOSIS; UNNECESSARY PROCEDURE; VIRUS PNEUMONIA; WASTING SYNDROME;

EID: 33749014667     PISSN: 17426405     EISSN: None     Source Type: Journal    
DOI: 10.1186/1742-6405-3-20     Document Type: Article

References (13)

1. CDC: CD4 and T-cell determinations. Report of results for the performance evaluations survey conducted in October 2003. CDC model performance evaluation program.
2. Malone JL, Simms TE, Gray GC, Wagner KF, Burge JR, Burke DS: Sources of variability in repeated T-helper lymphocyte counts from human immunodeficiency virus type I-infected patients: Total lymphocyte count fluctuations and diurnal cycle are important. J Acquired Immune Deficiency Syndromes 1990, 3-144-151.
3. CDC: Revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR 1992, 41:RR-17.
4. CDC: Guidelines for preventing opportunistic infections among HIV-infected persons-2002. MMWR 2002, 55:RR-08.
5. Stein DS, Korvick JA, Vermund SH: CD4+ lymphocyte cell enumeration for prediction of clinical course of human immunodeficiency virus disease: a review. J Infect Diseases 1992, 165:352-363.
6. Masur H, Ognibene FP, Yarchoan R, Shelhamer JH, Baird BF, Travis W, Suffredini AF, Deyton L, Kovacs JA, Falloon J, Davey R, Polis M, Metcalf J, Baseler M, Wesley R, Gill V, Fauci A, Lane HC: CD4 counts as predictors of opportunistic pneumonias in human immunodeficiency virus (HIV) infection. Ann Int Med 1989, 111:223-231.
7. Burcham J, Marmor M, Dubin N, Tindall B, Cooper DA, Berry G, Penny R: CD4% is the best predictor of development of AIDS in a cohort of HIV-infected homosexual men. AIDS 1991, 5:365-372.
8. 3. J Infect Diseases 2005, 192:950-957.
9. Cox DR, Snell EJ: The analysis of binary data. 2nd edition. London: Chapman & Hall; 1989.
10. Beck EJ, Kupek EJ, Gompels MM, Pinching AJ: Correlation between total and CD4 lymphocyte counts in HIV infection: not making the good an enemy of the not so perfect. Int J STD AIDS 1996, 7:422-428.
11. Gebo KA, Gallant JE, Keruly JC, Moore RD: Absolute CD4 vs CD4 percentage for predicting the risk of opportunistic illness in HIV infection. J Acquir Immune Defic Syndrome 2004,36:1028-1033.
12. CDC: 1993 Revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMRW 1992, 41:RR-17.
13. Bonnet F, Thiebaut R, Chene G, Nean D, Pellegrin JL, Mercie P, Beylot J, Dabis F, Salamon R, Morlat P, Groupe d'Epidemiologic Clinicque du SIDA en Aquitaine (GECSA): Determinants of clinical progression in antiretroviral-naïve HIV-Infected patients starting highly active antiretroviral therapy. Aquitaine Cohort, France 1996-2002. HIV Medicine 2005, 6:198-205.